These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 3282934)

  • 41. [Progestins and arterial disease].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):344-52. PubMed ID: 12280205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormonal replacement and lipid changes in postmenopausal women.
    Limpaphayom K; Taechakraichana N; Jaisamrarn U
    J Med Assoc Thai; 1996 Jan; 79(1):10-5. PubMed ID: 8867395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
    Kistner RW
    Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study.
    Vaziri SM; Evans JC; Larson MG; Wilson PW
    Arch Intern Med; 1993 Oct; 153(19):2200-6. PubMed ID: 8215723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The significance of ovarian and testicular steroids in lipid metabolism and atherogenesis].
    Marek J
    Vnitr Lek; 1992 Sep; 38(9):913-20. PubMed ID: 1481391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Women, lipoproteins, and cardiovascular disease risk.
    LaRosa JC
    Int J Fertil; 1992; 37 Suppl 2():63-71. PubMed ID: 1354661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Oral contraceptives and metabolic changes].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of sex steroids on lipids and lipoproteins.
    Samsioe G
    Postgrad Med; 1989 Apr; Spec No():59-63; discussion 89-90. PubMed ID: 2726628
    [No Abstract]   [Full Text] [Related]  

  • 56. Oral contraceptives and metabolic risk markers for coronary heart disease.
    Crook D; Godsland IF; Wynn V
    Int J Fertil; 1991; 36 Suppl 1():38-46. PubMed ID: 1678380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effects of androgens and other sex hormones on serum lipoproteins].
    Reiner Z
    Lijec Vjesn; 1996 Mar; 118 Suppl 1():33-7. PubMed ID: 8759406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Significance of hormonal contraceptives for coronary heart disease].
    Gohlke-Bärwolf C
    Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sex steroids and vascular risk].
    Rozenbaum H
    Coeur; 1983; 14(1):91-102. PubMed ID: 12339512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.